Survival of pediatric patients after relapsed osteosarcoma: The St. Jude Children's Research Hospital experience

Cancer

Volumn 119, Issue 14, 2013, Pages 2645-2653

  Leary, Sarah E S ^a,b,c   Wozniak, Amy W ^a   Billups, Catherine A ^b   Wu, Jianrong ^a   McPherson, Valerie ^a,b   Neel, Michael D ^a   Rao, Bhaskar N ^a   Daw, Najat C ^a,b,d  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

chemotherapy; osteosarcoma; outcome; prognostic factors; relapse; survival

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; BRAIN ARTERY ANEURYSM; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EVENT FREE SURVIVAL; FEMALE; GLIOBLASTOMA; HUMAN; LUNG METASTASIS; MALE; OSTEOSARCOMA; PEDIATRIC HOSPITAL; POSTRELAPSE SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; THORACOTOMY;

CHEMOTHERAPY; OSTEOSARCOMA; OUTCOME; PROGNOSTIC FACTORS; RELAPSE; SURVIVAL;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MEDICAL RECORDS; NEOPLASM GRADING; OSTEOSARCOMA; RECURRENCE; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; TENNESSEE; YOUNG ADULT;

EID: 84879676594     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28111     Document Type: Article

References (14)

1. Bacci G, Longhi A, Fagioli F, Briccoli A, Versari M, Picci P,. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy. Eur J Cancer. 2005; 41: 2836-2845.
2. Longhi A, Errani C, De Paolis M, Mercuri M, Bacci G,. Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev. 2006; 32: 423-436.
3. Meyer WH, Pratt CB, Poquette CA, et al. Carboplatin/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial. J Clin Oncol. 2001; 19: 171-182.
4. Bacci G, Briccoli A, Longhi A, et al. Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy. Acta Oncol. 2005; 44: 748-755.
5. Chou AJ, Merola PR, Wexler LH, et al. Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience. Cancer. 2005; 104: 2214-2221.
6. Crompton BD, Goldsby RE, Weinberg VK, et al. Survival after recurrence of osteosarcoma: a 20-year experience at a single institution. Pediatr Blood Cancer. 2006; 47: 255-259.
7. Hawkins DS, Arndt CA,. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy. Cancer. 2003; 98: 2447-2456.
8. Kempf-Bielack B, Bielack SS, Jürgens H, et al. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol. 2005; 23: 559-568.
9. Saeter G, Høie J, Stenwig AE, et al. Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival. Cancer. 1995; 75: 1084-1093.
10. Tabone MD, Kalifa C, Rodary C, Raquin M, Valteau-Couanet D, Lemerle J,. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy. J Clin Oncol. 1994; 12: 2614-2620.
11. Mahajan A, Woo SY, Kornguth DG, et al. Multimodality treatment of osteosarcoma: radiation in a high-risk cohort. Pediatr Blood Cancer. 2008; 50: 976-982.
12. Bielack SS, Kempf-Bielack B, Branscheid D, et al. Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. J Clin Oncol. 2009; 27: 557-565.
13. Ferrari S, Briccoli A, Mercuri M, et al. Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival. J Clin Oncol. 2003; 21: 710-715.
14. Bacci G, Ferrari S, Longhi A, et al. Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy. Eur J Cancer. 2001; 37: 32-38.